MSB 3.21% $1.13 mesoblast limited

Ann: Update on BLA for Graft Versus Host Disease, page-739

  1. 7,859 Posts.
    lightbulb Created with Sketch. 1350
    This is easy to look up.

    Below is a Cochrane systematic review of a number of RCTs. This is nearly as high quality evidence as you can get in science. It's a review of a bunch of different RCTs - much higher evidence than an individual RCT, for those that don't know (I assume you do Stan, you do seem to do your research which I appreciate).

    This. This is a study that impacts the way medical professionals think and practice. This is strong evidenced based medicine.

    I've screen shotted some relevant results. If you're actually interested in knowing, read the paper.

    I'm not here to debate vaccines. I've had enough of that BS over the years. DYOR.
    https://hotcopper.com.au/data/attachments/5484/5484001-3b77b5ef7ac62eab7ecf1ba8f8f97de4.jpg
    https://hotcopper.com.au/data/attachments/5484/5484004-d9a096229e692684a68c1ad7f608a223.jpg
    https://hotcopper.com.au/data/attachments/5484/5484007-1777ca45a278032be3951018871600eb.jpg
    Last edited by DocMcstuffins: 05/08/23
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.